News

Press Release

Go to Topics

Back number

2014

Sysmex Launches the New Automated Hematology Analyzer XN-L series - a Compact Model in the XN Family
- Meets Laboratory Needs in Both Emerging and Advanced Markets -
Sysmex Establishes New Subsidiary in Australia
- Aiming to Further Increase the Company's Presence in the Asia-Pacific Region -
Sysmex Launches a New Product in the Cytoscreening Field, the LC-1000 Exfoliative Cell Analyzer
- Aiming to Enhance the Efficiency of Future Cervical Cancer Screening Tests -
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2015 (PDF:377KB)
Announcement Regarding Revision of Business Forecasts (PDF:93KB)
Sysmex Announces Revisions to Dividends from Surplus (Interim) and Year-End Dividend Forecast (PDF:86KB)
Sysmex Wins Awards in 2014 Local Commendation for Kinki Inventions
Announcement Regarding Revision of Business Forecasts (PDF:81KB)
Sysmex Selected by the Securities Analysts Association of Japan for Excellence in Disclosure to Individual Investors for the Third Consecutive Year
Sysmex Selected for Inclusion in the Asia Pacific Index of the Dow Jones Sustainability Indexes for Third Consecutive Year
Sysmex to Establish New Japanese Base within IMP on Kobe Port Island to Develop Companion Diagnostics Drugs toward the Realization of Personalized Medicine
Sysmex Establishes New Measurement Technology that Achieves Even Higher Sensitivity for Its HISCL®-Series Immunochemistry Testing Analyzers
Sysmex Launches New Automated Blood Coagulation Analyzer Models, the CS-2400/2500
Sysmex Launches the Automated Immunoassay System HISCL®-800, a Compact Analyzer for Immunochemistry Testing
- Space-saving and High-performance in Response to Increasingly Diverse Needs -
First Japanese-Made Automated Hematology Analyzer Certified under the 3rd Heritage Program of Legacy Analytical Instruments/Scientific Instruments
Sysmex Receives MHLW Approval to Manufacture and Market Reagent to Monitor Therapeutic Gains on Chronic Myelogenous Leukemia (CML), Japan's First to Report on the International Scale (IS)
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2015 (PDF:390KB)
Sysmex's New Instrument Factory, i-Square, Opens in the City of Kakogawa, Hyogo Prefecture
Sysmex and Toppan Printing to Collaborate in the Genetic Analysis Testing Industry
Sysmex Inostics GmbH to Collaborate with Merck KGaA to Develop and Commercialize a Blood-Based RAS Biomarker Test for Patients with Metastatic Colorectal Cancer
Sysmex Launches LIASAUTO P-FDP Hemostasis Reagent
-Enhanced Reagent Performance Leading to Higher Testing Efficiency and Cost Reductions-
Consolidated Financial Results for the Year Ended March 31, 2014 (PDF:340KB)
Sysmex Announces Changes from Financial Results and Year-End Dividend Forecasts for the Fiscal Year Ended March 31, 2014 (PDF:79KB)
Announcement of Executive Change (PDF:112KB)
Sysmex to Expand Reagent Factories in Germany and Singapore
- Working to Meet Growing Global Demand -
Sysmex Establishes New Subsidiary in Colombia
- Enhancing Sales and Support Networks in Emerging Markets -
Sysmex Reinforces Direct Sales and Support Network in India to Expand Business in Non-Hematology Fields
Sysmex to Launch the HISCL® TARC Assay Kit for Atopic Dermatitis
- Allows for Automated Testing in Only 17 Minutes -
Sysmex Receives the Fiscal 2014 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (Prize for Science and Technology)
Sysmex to Be Special Sponsor of the Kobe Marathon 2014
- We are pleased to have sponsored this exciting event since its inception in 2011 -
Sysmex Accredited for ISO/IEC 17025 and ISO/IEC 17043 Calibration Laboratory and Proficiency Testing Provider
- Initiatives toward Further Standardization of Clinical Testing and Quality Improvement -
Sysmex Enters into Clinical Research, Joint Development and Licensing Agreement with Merck Millipore
-Accelerating the Creation of New Cell Analysis Technologies with a View to Personalized Medicine-
Announcement of Organizational and Personnel Changes (PDF:133KB)
Promoting Initiatives to Enhance Clinical Value of the OSNA® Method
- Further Raising Value by Improving Workflow in the Detection of Breast Cancer Lymph Node Metastasis -
(Correction) Partial Correction to Announcement of Stock Split and Corresponding Revisions to the Articles of Incorporation (PDF:36KB)
Announcement of Stock Split and Corresponding Revisions to the Articles of Incorporation (PDF:95KB)
FY2013 Nakatani Award and Research Grant Recipients Announced (PDF:79KB)
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2014 (PDF:124KB)
Sysmex Reinforces Sales and Support Structure in Turkey
- Establishes Local Subsidiary to Expand Business in Growing Market -
Sysmex Launches New ASTRIM FIT Product for Noninvasive Measurement of Estimated Hemoglobin Levels
- Wide support for condition management, from top athletes to people who attend fitness clubs -